Ocular hypertension treatment study

Comment

Michael E Yablonski. Arch Ophthalmol. 2004 Jul.

. 2004 Jul;122(7):1088-9; author reply 1089.

doi: 10.1001/archopht.122.7.1088.

No abstract available

Comment on

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. Kass MA, et al. Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30. doi: 10.1001/archopht.120.6.701. Arch Ophthalmol. 2002. PMID: 12049574 Clinical Trial.
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. Gordon MO, et al. Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30. doi: 10.1001/archopht.120.6.714. Arch Ophthalmol. 2002. PMID: 12049575 Clinical Trial.